To make the bioeconomy real, develop for scalability and creditworthiness Read more x
Press releases

Blue Horizon appoints Przemek Obloj to lead expansion into growth capital

By Blue Horizon

Zurich, 17 November 2020 – Blue Horizon, a pure play thematic impact asset manager in the alternative protein sector, announced that Przemek Obloj has joined the Company as a Managing Partner.

Przemek Obloj joins the Executive Team of Blue Horizon with responsibility for the Company’s growth capital and private equity business, expanding Blue Horizon’s investment universe beyond its successful seed and venture capital operations. He brings more than 15 years of investing experience from leading global organisations including CVC Capital Partners and EQT Partners. Prior to joining Blue Horizon, Przemek was the Managing Director and Head of European Private Equity at PSP Investments, a C$ 170 billion Canadian pension investment manager. He started his career at McKinsey & Company and holds a MSc in Finance from Warsaw School of Economics and an MBA from INSEAD in Fontainebleau and Singapore.

The global food sector is changing at an unprecedented pace as consumers increasingly choose to replace animal proteins with healthier and more sustainable alternatives. Blue Horizon enables this transformation by investing in innovative companies across the globe, generating positive impact and sustainable, long-term returns.

Björn Witte, CEO of Blue Horizon, said: “We are delighted to welcome Przemek to Blue Horizon in those exciting times for the sector. He brings extensive experience and an impressive investment track record in consumer, technology and life sciences sectors and in building successful investment organisations. Having worked with him on both transactions and refining our organisation, I could not think of a better partner for the future. Under his leadership, Blue Horizon’s growth capital will complement our existing verticals, from seed stage and venture capital to the operational platforms such as ‘the Live Kindly Collective’ which we set-up in 2019 and continue to support as the controlling shareholder.”

About Blue Horizon Corporation
Blue Horizon has shaped the growth of the alternative proteins market since its beginning as a pure play thematic impact investor with unparalleled access to the food 4.0 ecosystem. The company aims to transform the global food industry through investments into and value creation for companies along their lifecycles, replacing animal proteins with healthy and sustainable alternative protein sources. Blue Horizon was founded by Roger Lienhard and is based in Zurich and Los Angeles. It completed over 55 investments in the alternative protein food tech sector and raised and invested more than CHF 500 million. Its business model offers a unique opportunity to benefit from this global megatrend while contributing to a healthier and more sustainable world.

Media contact
Martin Meier-Pfister, IRF
Phone +41 43 244 81 40